Template for Submission of Research Concepts for Consideration by the D:A:D Steering Committee
The D:A:D study is a prospective multi-cohort study of HIV-positive persons under active follow-up.

The study was established in 1999 to assess the incidence of myocardial infarction in HIV-positive persons receiving anti-retroviral therapy. Since then the research agenda has expanded to include other clinical endpoints such as stroke, diabetes, cancers, end-stage liver and renal disease and mortality.

The D:A:D Steering Committee (SC) consists of cohort representatives, central statisticians, member from the HAART Oversight Committee and the D:A:D chair.

The SC encourages the submission of concepts for new research projects. Concepts can be submitted for review by the D:A:D SC using the template below
Contact Information
Research Concept
Title [Limit approximately 
Scientific Rationale/Background [Limit approximately 
Aims and Hypothesis [Limit approximately 
References [up to 5 references on which study rational is based]
Study population
Public health or clinical relevance [limit approximately 
Time frame (for initiation and completion of suggested concept)
Once submitted the research concept will undergo review by the D:A:D SC for evaluation of the following:
  • Scientific relevance
  • Relevance to the D:A:D Study
  • Design and feasibility
  • Statistical power and feasability
  • Overlap with already approved projects
Upon completion of the review, feedback will be provided to the
proposer(s). In some circumstances, a revision of the concept may be requested.

If the concept is approved for implementation, a writing group will be established consisting of the proposers (up to 3 persons that were centrally involved in the development of the concept) and members of the D:A:D Steering Committee (or other appointed cohort representatives) Statistical department and Coordinating Center.

All persons involved in the process of reviewing these research concepts are bound by confidentiality.
Enter the code shown above in the box below.